The reduce in paclitaxel CL observed during the existence of zosuquidar triggered a rise in time which the plasma paclitaxel concentration remains higher than 0.one mol L−one, which is known to become a marker of both toxicity (neutropenia) and efficacy [one]. Although the influence of zosuquidar about the toxicity of https://werneri554tfp7.wikifordummies.com/user